Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
Michiro Susa(National Defense Medical College Hospital), Zhenfeng Duan(University of Miami)
Cited by 161
Related Papers
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
|Oncotarget|2017|208
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
|Scientific Reports|2015|156
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
|Oncotarget|2015|103